Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terutroban versus aspirin for platelet function in type 2 diabetes
2008-005262-31Phase 2Terminated
- Sponsor
- Servier
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of terutroban in platelet hyperreactivity in type 2 diabetes mellitus (PHR) (2 arms), sponsored by Servier. Primary endpoint: Percentage of platelet aggregation. Started Nov 2008; status: terminated.
02
Drugs
terutroban
03
Conditions
platelet hyperreactivity in type 2 diabetes mellitus (PHR)
Beyond the preview
Go deeper on 2008-005262-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005262-31.